DREDGECAP
NASDAQ·Surgical & Medical Instruments & Apparatus
DXCM

DEXCOM INC

DEXCOM INC (ticker: DXCM) is an NASDAQ-listed surgical & medical instruments & apparatus company. Its most recent SEC filing was a 8-K dated 2026-05-15. DredgeCap's extraction of DXCM's SEC filings surfaces no active distress signals from the most recent annual filing. DXCM reported $1.19B in revenue and $199.50M for the period ending 2026-03-31, with operating cash flow of $525.60M. Cash and equivalents stood at $1.12B (up 23.6% year-over-year). Total assets of $6.63B exceed total liabilities of $3.68B. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

DXCM Overview
10-KFebruary 9, 20232/9/23· Fiscal Year Ended December 31, 2022· FY-End 12/31/22

DXCM10-K Filing

Track for Alerts

Financial Highlights

Structured-data extract from the filer's SEC-tagged XBRL. Every value below is sourced from a labeled XBRL concept; hover any cell to see the exact source. No AI summarization, no paraphrasing.

Income Statement

ItemDec 31, 2022Dec 31, 2021YoY
Revenue$2.91B$2.45B↑ +18.8%
Cost of Revenue$1.03B$768.00M
Operating Income (Loss)$391.20M$265.80M↑ +47.2%
Net Loss from Continuing Operations(derived)$341.20M$216.90M↑ +57.3%
Net Income (Loss) — Total$341.20M$216.90M↑ +57.3%

Balance Sheet

ItemDec 31, 2022Dec 31, 2021YoY
Total Assets$5.39B$4.93B
Total Liabilities$3.26B$2.89B
Stockholders' Equity$2.13B$2.04B↑ +4.4%
Accumulated Deficit$479.90M$138.70M
Cash and Cash Equivalents$642.30M$1.05B↓ -39.0%
Shares Outstanding386.30M388.00M

Cash Flow

ItemDec 31, 2022Dec 31, 2021YoY
Operating Cash Flow$669.50M$442.50M↑ +51.3%
Source filings — every value above is extracted verbatim from these SEC submissions:

DXCM Legal Proceedings Disclosed

Other Proceeding
Extracted from DXCM’s 10-K filed February 9, 2023. The text below is the company’s own disclosure language; DredgeCap has not paraphrased, classified, or summarized it.
Disclosure:Legal proceedings described above may contain allegations that have not been proven. Filings often disclose claims that are later dismissed, settled, or resolved without admission of wrongdoing. DredgeCap surfaces the company’s own disclosure language for investor-risk research only. This is not legal advice or investment advice.
Current DredgeCap Risk Profile
3.2/10
MODERATE RISK
Dilution Risk
LOW2.5/10
Liquidity Risk
LOW2.0/10
Debt Toxicity
MODERATE3.5/10
Profitability Risk
LOW2.8/10
Going Concern✓ Not flagged
The risk profile above reflects the latest cached DredgeCap analysis for DXCM. For the full filing-by-filing analyst report (red flags, primary risk driver, what moves the stock), open DXCM's company page.

What is a 10-K?

An annual report providing a comprehensive overview of the company's business and financial condition. Includes audited financial statements (signed off by an independent PCAOB-registered accounting firm), Risk Factors, Business description, MD&A, and disclosures about legal proceedings, controls, and corporate governance. The 10-K is the most important filing in US public-company disclosure.

More on DXCM

Dilution Analysis
Debt Structure
Going Concern
Full Financials
Form-type explainers and 8-K item descriptions are derived from SEC documentation. Financial values are extracted from SEC-tagged XBRL — see the "Source filings" list above each table for direct EDGAR links to every cited filing. This page does not constitute investment advice. Always consult the original filing on SEC EDGAR for authoritative content, and consult a licensed financial advisor for investment decisions.